688298 东方生物
2024/09 - 九个月
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额(367,153)(1,645,591)2,995,9245,203,8541,790,307
投资活动产生之现金流量净额(253,584)(2,117,755)(2,375,700)(321,637)(548,836)
筹资活动产生之现金流量净额(374,987)49,536(698,248)(509,174)503,294
汇率变动对现金及现金等价物的影响9,88985,852536,645(75,440)(29,777)
现金及现金等价物净增加/(减少)(985,835)(3,627,957)458,6224,297,6031,714,988
期初现金及现金等价物余额2,928,6036,556,5606,097,9381,800,33585,347
期末现金及现金等价物余额1,942,7692,928,6036,556,5606,097,9381,800,335